Compound ID | 3602
Synonym(s): Ro 139904 | Ro139904
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against beta-lactamase-producer and non-producer strains of Escherichia coli, Serratia marcescens, Enterobacter cloacae, Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria gonorrhoeae; cell wall synthesis inhibitor |
| Description: | Synthetic compound; parenteral cephalosporin; (6R,7R)-7- {2-(2-amino-4-thiazolyl)-2-[(Z)-methoxyimino] acetamido)-3- {[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid disodium salt; shows superior efficacy to cefotaxime in treating septicaemia in mice |
| Institute where first reported: | Pharmaceutical Research Department, F. Hoffmann-La Roche & Co., Ltd., Switzerland |
| Year first mentioned: | 1980 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9570985 |
| Citations: |
|